Loading clinical trials...
Loading clinical trials...
A Randomized Controlled Trial of Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
Conditions
Interventions
Intensified post-discharge surveillance
Standard post-discharge surveillance
Locations
1
United States
Fox Chase Cancer Center - Philadelphia
Philadelphia, Pennsylvania, United States
Start Date
October 14, 2022
Primary Completion Date
November 1, 2028
Completion Date
November 1, 2028
Last Updated
July 8, 2025
NCT06316895
NCT06305754
NCT03375307
NCT05198830
NCT05245812
NCT06345508
Lead Sponsor
Fox Chase Cancer Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions